Clindamycin Phosphate - Benzoyl Peroxide Gel
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D223R0012
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents5
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued an award notice for the procurement of Clindamycin Phosphate - Benzoyl Peroxide Gel. This notice, identified by procurement number SPE2D223R0012, reflects a modification to the contract, specifically to add a clause. The procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified by Product Service Code 6505, indicating drugs and biologicals.
The place of performance for this contract is specified as Yeruham, Jerusalem (IL-JM), Israel, highlighting the international scope of the activity. The contracting entity is DLA Troop Support, a federal office within the Defense Logistics Agency, which is responsible for ensuring the supply of critical pharmaceutical products to support military and defense operations.
The primary objective of this procurement is to secure a reliable supply of Clindamycin Phosphate - Benzoyl Peroxide Gel, a pharmaceutical product used for medical purposes, likely in the treatment of skin conditions such as acne. The modification to add a clause suggests ongoing contract management and compliance adjustments, ensuring that the agreement remains current and effective throughout its lifecycle.
Key requirements and expected deliverables include the manufacturing and delivery of the specified pharmaceutical gel, adhering to the standards and regulations outlined by the DLA and relevant federal guidelines. Contractors must demonstrate capabilities in pharmaceutical preparation manufacturing, with a proven track record of quality, reliability, and compliance with international performance locations.
The notice remains active as of the posting date, October 28, 2026, and interested parties can access further details and attachments via the SAM.gov opportunity link provided. For inquiries or additional information, contractors may contact Courtney Hunter ([email protected], (445) 737-3585) or Jason Wray ([email protected], 445-737-6304).
This opportunity is particularly relevant for contractors with expertise in pharmaceutical manufacturing and international logistics, seeking to support the Department of Defense’s medical supply chain. The contract’s core elements—product specifications, place of performance, and compliance requirements—will remain consistent throughout its duration, ensuring stability and clarity for participating vendors.